RecruitingNot ApplicableNCT06162195

The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement

Sponsor

Embody Orthopaedic Limited

Enrollment

200 participants

Start Date

Jul 21, 2026

Study Type

INTERVENTIONAL

Conditions

Osteoarthritis, Hip Inflammatory Arthritis

Summary

The goal of this randomised controlled trial is to compare the success of two types of hip replacement in patients with hip arthritis. The main question it aims to answer is whether a new type of hip replacement (called a hip resurfacing) can be as successful as an existing hip replacement (called a total hip replacement). Patients will be given either the new hip resurfacing or the existing total hip replacement and researchers will compare their function, complication rate and physical activity.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Cementless total hip replacement and a medical device called The H1 Implant for people with inflammatory arthritis and osteoarthritis, hip. The study is currently recruiting participants at 3 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEThe H1 Implant

Patients allocated to The H1 Implant arm will be implanted with the H1 Implant which is a cementless, ceramic hip resurfacing device.

DEVICECementless total hip replacement

Patients allocated to cementless total hip replacement arm will be implanted with a cementless ceramic-on-poly or ceramic-on-ceramic total hip replacement